Skip to content

Clinical trials

Phase 4 Hypertension, Pulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 4 Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20063
20073
20081
20094
20103
20115
20122
20131
20144
20161
20172
20192
20211
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated13
Recruiting2
Withdrawn2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics6
Washington University School of Medicine3
Stanford University2
University of California, Los Angeles2
University of Pennsylvania2
Bayer1
Baylor College of Medicine1
Boston University1
Brigham and Women's Hospital1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary37
Pulmonary Arterial Hypertension9
Aortic Valve Stenosis3
Connective Tissue Diseases2
Heart Failure2
Heart Failure, Diastolic2
Hypertrophy, Left Ventricular2
Scleroderma, Systemic2
Altitude Sickness1
Dyspnea1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.